דוטסטריד תרו - Dutasteride taro

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)

G04CB
Testosterone-5-alpha reductase inhibitors

××¨××× ×¤×¢×× (ATC5)

Dutasteride 0.5 MG âG04CB02

×¦××¨×ª ××ª×

×¤××× - PER OS

×¦××¨×ª ××× ××

×§×¤×¡××××ª ×¨×××ª, CAPSULES SOFT
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH). Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

12/01/2014

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª
××××¤×× ×××××× ×©×¤××¨× ×©× ××¢×¨××× ××ª.	12/01/2014	×××¨××××××	DUTASTERIDE, FINASTERIDE	BPH

×©××××© ××¡×

××¡××¨×ª ××××× ××¡×

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

××× ×¢××× ××¨××¤×
Â

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 31.05.2018 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 31.05.2018 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 31.05.2018

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××××¡××¨×× ×ª×¨× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	LABORATORIOS LEÃN FARMA S.A, SPAIN
×©× ××¢× ××¨××©××	TARO INTERNATIONAL LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 2/2017. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	{{{×ª××¨×× ×¢××××}}}

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

השינוי האחרון נעשה בֹ־21 ביוני 2024 ב־02:50

דוטסטריד תרו - Dutasteride taro

ויקיתרופות